{"id":"W4380078597","doi":"10.1002/hon.3196_lba4","title":"TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Follicular lymphoma; Gastroenterology; Clinical endpoint; Oncology; Rituximab; Phases of clinical research; Neutropenia; Lymphoma; Surgery; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00168515,0.001047184,0.0009372025,0.0002769273,0.000224104,0.0008783487,0.0007081064,0.000917435,0.005394869],"category_scores_gemma":[0.0007670205,0.0003460911,0.001197689,0.0002029748,0.0004399006,0.000623097,0.0003924611,0.001980939,0.001173803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005723734,"about_ca_system_score_gemma":0.0007625184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003834367,"about_ca_topic_score_gemma":0.00127638,"domain_scores_codex":[0.9997334,0.0001277612,0.00001276051,0.00004923063,0.00003542248,0.00004141454],"domain_scores_gemma":[0.999588,0.00006944283,0.0001173949,0.00003262144,0.0000401244,0.0001524387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6027034,0.03660038,0.01535466,0.002767577,0.003318719,0.0004921399,0.0004010836,0.0032529,0.0923029,0.0005990104,0.01685691,0.2253503],"study_design_scores_gemma":[0.4967419,0.4329006,0.0289112,0.0002378419,0.002779027,0.001381912,0.0001243928,0.001807115,0.01392082,0.0005222034,0.0206029,0.00007016615],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733891,0.009009861,0.001534623,0.001047801,0.000180141,0.003026518,0.005457252,0.0003256484,0.006029089],"genre_scores_gemma":[0.9743599,0.00362648,0.002335733,0.001546155,0.0002238606,0.002725126,0.009723932,0.0001017655,0.005357108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005394869,"threshold_uncertainty_score":0.01804763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02644501582058063,"score_gpt":0.3272590848480463,"score_spread":0.3008140690274657,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}